Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Bulletin Du Cancer|March 30, 2004
[Saccharomyces cerevisiae: an efficient tool and model system for anticancer research]Jean-Emmanuel Kurtz, Patrick Dufour, Brigitte Duclos, et al.
Presse Medicale (Paris, France : 1983)|November 4, 2004
Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis. A study of 91 patients from a single centerFréderic Maloisel, Emmanuel Andrès, Georges Kaltenbach, et al.
Anticancer Research|May 17, 2002
Effects of combinations of 7beta-hydroxycholesterol and anticancer drugs or ionizing radiation on the proliferation of cultured tumor cellsJin Won Hyun, Vincent Holl, Denis Weltin, et al.
Sarcoma|June 4, 2008
Diffuse primary angiosarcoma of the pleura: a case report and review of the literatureJean-Emmanuel Kurtz, Sebastian Serra, Brigitte Duclos, et al.
The American Journal of Medicine|April 20, 2004
Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term resultsFrédéric Maloisel, Emmanuel Andrès, Jacques Zimmer, et al.
Cancer Letters|March 11, 2008
High-LET radiation combined with oxaliplatin induce autophagy in U-87 glioblastoma cellsSami Benzina, Anaïs Altmeyer, Faten Malek, et al.
Cancer Letters|March 27, 2007
The cytotoxicity of high-linear energy transfer radiation is reinforced by oxaliplatin in human glioblastoma cellsSami Benzina, Frederic Debomy, Jean-Pierre Bergerat, et al.
Biochemical and Biophysical Research Communications|June 14, 2003
Caspase 8-mediated cleavage of the pro-apoptotic BCL-2 family member BID in p53-dependent apoptosisBarbara Fischer, David Coelho, Patrick Dufour, et al.
Critical Reviews in Oncology/Hematology|April 8, 2009
Geriatric oncology, general practitioners and specialists: current opinions and unmet needsJean-Emmanuel Kurtz, Damien Heitz, Philippe Enderlin, et al.
Breast Cancer Research and Treatment|September 9, 2010
Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancerThierry Petit, Marc Wilt, Michel Velten, et al.
Pageof 5